Dr Adrian Mander
Prosiectau fel Prif Ymchwiliwr
Prosiectau fel Cyd-Ymchwiliwr
- Centre for Trials Research - Core infrastructure funding (01.03.2020 - 31.03.2023)
- T1D-Plus: a clinical trial platform for combined beta cell preservation therapy (01.09.2022 - 31.08.2026)